期刊文献+

糖皮质激素诱导胰岛素抵抗的研究进展 被引量:5

Research pragress on Glucocorticoid-Induced Insulin Resistance
下载PDF
导出
摘要 体内糖皮质激素水平异常会引起糖、脂代谢紊乱,最终会发展成为以向心性肥胖、胰岛素抵抗为主要特征的库欣综合征或代谢综合征,严重危害人们的健康。研究糖皮质激素诱导胰岛素抵抗的病理机制有助于认识上述疾病的本质,更是有效治疗这些疾病的基础。本文总结了糖皮质激素诱导各受累组织或器官发生胰岛素抵抗分子机制的最新研究,并对研究糖皮质激素诱导胰岛素抵抗的实验方法学进行了简要介绍,以期对从事相关科研或临床工作的人员有所帮助。 High levels of glucocorticoids can cause glucose and lipid dysmetabolism,and finally lead to Cushing′s syndrome or metabolic syndrome which are featured as central obesity and insulin resistance.The two diseases vital-ly destroy human′s health.It is very important to study the mechanism of glucocorticoids-induced insulin resistance, since it is the basis of better understanding and cure of these two diseases.We presented the latest research achieve-ments on the mechanism of glucocorticoids-induced insulin resistance in each targeted tissues,and we also introduced the methodology of related research on this field in our article.
出处 《海峡药学》 2015年第5期1-5,共5页 Strait Pharmaceutical Journal
基金 中国药科大学大学生创新训练计划项目(J1030830)
关键词 糖皮质激素 胰岛素抵抗 地塞米松 Glucocorticoid Insulin Resistance Dexamethasone
  • 相关文献

参考文献44

  • 1AMATRUDA J M,DANAHY S A,CHANG C L.The effects of glucocorticoids on insulin-stimulated lipogenesis in primary cultures of rat hepatocytes[J].The Biochemical journal,1983,212(1):135-141.
  • 2ZHAO L F,IWASAKI Y,HE W,et al.Hormonal Regulation of AcetylCo A Carboxylase Isoenzyme Gene Transcsiption[J].Endocrine Journal,2010,57(4):317-324.
  • 3DOLINSKY V W,DOUGLAS E N,LEHNER R,et al.Regulation of the enzymes of hepatic microsomal triacylglycerol lipolysis and re-esterification by the glucocorticoid dexamethasone[J].Biochemical Journal,2004,378:967-974.
  • 4ASRIH M,JORNAYVAZ F R.Metabolic syndrome and nonalcoholic fatty liver disease:Is insulin resistance the link[J].Mol Cell Endocrinol,2015.
  • 5CHAVEZ J A,SUMMERS S A.A ceramide-centric view of insulin resistance[J].Cell Metab,2012,15(5):585-594.
  • 6BIKMAN B T,SUMMERS S A.Ceramides as modulators of cellular and whole-body metabolism[J].J Clin Invest,2011,121(11):4222-4230.
  • 7BOSLEM E,MACINTOSH G,PRESTON A M,et al.A lipidomic screen of palmitate-treated MIN6 beta-cells links sphingolipid metabolites with endoplasmic reticulum(ER)stress and impaired protein trafficking[J].Biochem J,2011,435(1):267-276.
  • 8KINOTE A,FARIA J A,ROMAN E A,et al.Fructose-induced hypothalamic AMPK activation stimulates hepatic PEPCK and gluconeogenesis due to increased corticosterone levels[J].Endocrinology,2012,153(8):3633-3645.
  • 9SLAVIN B G,ONG J M,KERN P A.Hormonal regulation of hormonesensitive lipase activity and mRNA levels in isolated rat adipocytes[J].J Lipid Res,1994,35(9):1535-1541.
  • 10VILLENA J A,ROY S,SARKADI-NAGY E,et al.Desnutrin,an adipocyte gene encoding a novel patatin domain-containing protein,is induced by fasting and glucocorticoids:ectopic expression of desnutrin increases triglyceride hydrolysis[J].J Biol Chem,2004,279(45):47066-47075.

二级参考文献28

  • 1杜文华,石建华,项平,陈凤玲.营养性肥胖大鼠模型的建立与血糖、血脂变化[J].蚌埠医学院学报,2007,32(4):379-381. 被引量:18
  • 2Dimitriadis G, Leighton B, Parry-Billings M, et al, Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle. Biochem J, 1997,321:707-712.
  • 3Delaunay F, Khan A, Cintra A, et al. Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids. J Clin Invest,1997,100: 2094-2098.
  • 4Ling ZC, Khan A, Delauny F, et al. Increased glucocorticoid sensitivity in islet beta-cells:effects on glucose 6-phosphatase, glucose cycling and insulin release. Diabetologia, 1998,41:634-639.
  • 5Walker BR, Phillips DIW, Noon JP, et al. Increased glueocorticoid activity in men with cardiovascular risk factors. Hypertension, 1998, 31:891-895.
  • 6Fraser R, IngTam MC, Anderson NH, et al. Cortisol effects on body mass, blood pressure, and cholesterol in the general population. Hypertension, 1999,33:1364-1368.
  • 7Reynolds RM, Walker BR, Syddall HE, et al. Altered control of cortisol secretion in adult men with low birth weight and cardiovascular risk factors. J Clin Endocrinol Metab,2001,86:245-250.
  • 8Whorwood CB, Donovan SJ, Flanagan D, et al. Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome. Diabetes, 2002, 51: 1066-1075.
  • 9Jamieson P M, Nyirenda M J, Walker B R, et al. Interactions between oestradiol and glucocorticoid regulatory effects on liver-specific glucocorticoid-inducible genes; possible evidence for a role of hepatic 11 betahydroxysteroid dehydrogenase type 1. J En
  • 10Levitt NS, Lambert EV, Woods D, et al. Impaired glucose tolerance and elevated blood pressure in low birthweight, nonobese, young south african adults: early programming of cortisol axis. J Clin Endocrinol Metab,2000,85:4611-4618.

共引文献12

同被引文献61

  • 1Sarkissian T, Beyenne J, Feldman B , et al. The complex nature of the interaction between disease activity and therapy on the lipid profile in patients with pediatric systemic lupus erythematosus[ J]. Arthrities Rheum,2006,54 (4) : 1283 - 1290.
  • 2Ettinger WH, Goldberg AP, Applebaum Bowden D, et al. Dyslipoproteinemia in systemic lupus erythematosus. Effect of corticosteroids[ J]. Am J Med,1987,83(3) :503 -508.
  • 3Svens0n KL, Lundqvist G, Wide L, et al. Impaired glucose handling in active rheumatoid arthritis, effects of corticosteroids and antirheumatic treatment [J ]. Metabolism, 1987,36 ( 10 ) - 944 - 948.
  • 4Petri M. Detection of coronary artery disease and the role of tradi- tional risk factors in the Hopkins Lupus Cohort [ J ] Lupus,2000,9 (3) :170 - 175.
  • 5Bazzan M, Vaccarino A, Marletto F. Systemic lupus erythematosus and thrombosis[ J]. Thromb J ,2015,13 : 16.
  • 6Skaggs B J, Hahn BH, McMahon M. Accelerated atherosclerosis in patients with SLE - mechanisms and management [ J ]. Nat Rev Rheumatol,2012,8 (4) : 214 - 223.
  • 7Pego - Reigosa JM, Rua - Figueroa l, Lopez - Longo FJ, et al. Analysis ,of disease activity and response to treatment in a largeSpanish cohort of patients with systemic lupus erythematosus[ J ]. Lupus,2015,24 (7) :720 - 729.
  • 8Sinieato NA, da Silva Cardoso PA, Appenzeller S. Risk factors in cardiovascular disease in systemic lupus erythematosus [ J ]. Curr Cardiol Rev,2013,9( 1 ) :15 -19.
  • 9PanaroUn D, Remillard P, Rouffard L, et al. Insulin resistance affects the regulation of lipoprotein lipase in the postprandial period and in an adipose tissue speeitfic manner [J]. Eur J Clin Invest, 2002,32(2) :84 -92.
  • 10Gazareen S, Fayez D, El - Najjar M, et al. Study of insulin resist- ance in patients with systemic lupus erythematosus and rheumatoid arthritis [ J ]. Menoufia Medical Journal,2014,27 ( 2 ) :215 - 225.

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部